Anthony P. Sileno

Suggest Changes
Learn More
The purpose of the current investigation was to optimize an intranasal (IN) galantamine (an acetylcholinesterase inhibitor used for treatment of Alzheimer's disease) formulation using an in vitro(More)
  • 1